Schedule 13D ownership disclosure
AQUINOX PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 03842B101
Event date: 2015-08-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,267,300
- Percent of class
- 39.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-047926
- Form type
- SC 13D
- Filer
- Neurogene Inc.
- CIK
- CIK 1404644
- Filed
- Aug 11, 2015
- Reporting period
- Aug 07, 2015
- Description
- Schedule 13D beneficial ownership